New York, September 2021: Axiom Market Research & Consulting™ added a report on home infusion market which includes study on product, application, and geography. The home infusion therapy market was projected to grow at a CAGR of 10.53% for the forecast period 2022 to 2028. The global market is estimated and forecasted in terms of revenue (USD Million) generated by the home infusion therapy market.

The factors like growing geriatric population, along with the advancements in technology and increasing prevalence of chronic disease had been majorly driving the home infusion therapy market. Several other factors like increasing prevalence of diseases and the chronic medical ailment like diabetes and cancer has been leading the requirement for the home infusion therapy across the globe. Because of the growing cases of the hospital acquired infections (HAI) has been creating new opportunities for the home infusion therapy market. The novel corona virus has also boosted the growth of the home infusion therapy market.

The report analyses the home infusion therapy market based on the product, application, and geography. By product, the home infusion therapy market includes infusion pump, intravenous sets, IV cannulas, and needleless connectors. By application, the home infusion therapy market is segmented into anti-infective, hydration therapy, chemotherapy, enteral nutrition, and parenteral nutrition. By geography, the home infusion therapy market is studied across the regions including North America, Europe, Asia-Pacific, and Rest of the World.

The infusion pump product segment is expected to have high market share in the home infusion therapy market

Because of the ability of the infusion pump for delivering the fluids in both small and large amounts, and the infusion can also be widely used for delivering the nutrients or medication, has been attributing to have the highest market share in the home infusion therapy market during the forecast period.

The anti-infective application segment is expected to dominate the home infusion therapy market during the forecast period

Due to the major use of the anti-infective application in the different procedure for the administration of the antibiotic and antifungal drugs, it is expected to dominate the home infusion therapy market during the forecast period. The anti-infective segment has been largely used for the purpose of preventing the infection including the antiviral, antifungal, antibacterial and antiparasitic infections.

The region of North America is expected to dominate the home infusion therapy market during the forecast period

North America is expected to witness the fastest growth in upcoming years owing to hold significant share in terms of value. Because of the presence of the advanced healthcare facilities, along with the continuously increasing adoption of the therapy based on the technology, the region of North America is expected to dominate the home infusion therapy market over the forecast period. The growing research and development, along with the product innovation has also contributed to increasing the demand for the home infusion therapy market across the region. United States followed by Canada and Mexico is projected to be the fastest growing market due to increasing consumers of products in the region. 

Key Players

The key players in the home infusion therapy market are B. Braun Melsungen AG, Becton, Dickinson and Company (BD) , NewIV , ICU Medical Inc, Plenum Tech Pvt Ltd, Baxter International Inc, JMS Co. Ltd, Silverline Meditech Pvt Ltd, Eli Lilly and Company , Fresenius Kabi, Terumo Corporation and AKAS Medical among others

Browse for More Details: https://www.axiommrc.com/product/11008-home-infusion-therapy-market-report

Contact Us:

Ganesh Sai

United States

3 Germay Dr.Ste 4 - 4666

Wilmington DE 19804

U.S.:- + 1 (845) 875-9786

U.K.:- + 44 (0) 20 3286 9707

Email: sales@axiommrc.com